Oak Thistle LLC Has $578,000 Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Oak Thistle LLC trimmed its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 3.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,574 shares of the company’s stock after selling 507 shares during the quarter. Oak Thistle LLC’s holdings in Acadia Healthcare were worth $578,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Harbor Capital Advisors Inc. boosted its stake in Acadia Healthcare by 302.0% during the fourth quarter. Harbor Capital Advisors Inc. now owns 90,772 shares of the company’s stock worth $3,599,000 after acquiring an additional 68,190 shares in the last quarter. Everence Capital Management Inc. bought a new position in shares of Acadia Healthcare during the 4th quarter worth about $203,000. GAMMA Investing LLC increased its position in Acadia Healthcare by 259.6% in the 4th quarter. GAMMA Investing LLC now owns 2,384 shares of the company’s stock valued at $95,000 after buying an additional 1,721 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after buying an additional 454,044 shares during the period. Finally, Principal Financial Group Inc. boosted its holdings in Acadia Healthcare by 2.1% in the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock worth $41,653,000 after acquiring an additional 13,368 shares in the last quarter.

Acadia Healthcare Stock Down 2.5 %

ACHC opened at $41.95 on Friday. The company’s 50-day moving average price is $40.65 and its two-hundred day moving average price is $57.47. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a twelve month low of $36.50 and a twelve month high of $87.77. The stock has a market cap of $3.90 billion, a price-to-earnings ratio of 13.75, a PEG ratio of 1.81 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same period last year, the business posted $0.91 earnings per share. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. As a group, equities analysts expect that Acadia Healthcare Company, Inc. will post 3.39 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ACHC. KeyCorp raised Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price on the stock in a research report on Tuesday, January 7th. TD Cowen reduced their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Royal Bank of Canada reiterated an “outperform” rating and set a $64.00 price target on shares of Acadia Healthcare in a research note on Friday, January 10th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, Acadia Healthcare presently has an average rating of “Moderate Buy” and an average price target of $70.22.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.